Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 96

1.

Trends and Patient Characteristics Associated with Tobacco Pharmacotherapy Dispensed in the Veterans Health Administration.

Ignacio RV, Barnett PG, Kim HM, Geraci MC, Essenmacher CA, Hall SV, Chow A, Pfeiffer PN, Sherman SE, Bohnert KM, Zivin K, Duffy SA.

Nicotine Tob Res. 2018 Sep 4;20(10):1173-1181. doi: 10.1093/ntr/ntx229.

PMID:
30184237
2.

Effectiveness of tobacco cessation pharmacotherapy in the Veterans Health Administration.

Duffy SA, Ignacio RV, Kim HM, Geraci MC, Essenmacher CA, Hall SV, Chow A, Pfeiffer PN, Sherman SE, Bohnert KM, Zivin K, Barnett PG.

Tob Control. 2018 Sep 4. pii: tobaccocontrol-2018-054473. doi: 10.1136/tobaccocontrol-2018-054473. [Epub ahead of print]

PMID:
30181383
3.

Effect of Interferon-Free Regimens on Disparities in Hepatitis C Treatment of US Veterans.

Barnett PG, Joyce VR, Lo J, Gidwani-Marszowski R, Goldhaber-Fiebert JD, Desai M, Asch SM, Holodniy M, Owens DK.

Value Health. 2018 Aug;21(8):921-930. doi: 10.1016/j.jval.2017.12.025. Epub 2018 Mar 7.

PMID:
30098669
4.

Leveraging routine clinical materials and mobile technology to assess CBT fidelity: the Innovative Methods to Assess Psychotherapy Practices (imAPP) study.

Wiltsey Stirman S, Marques L, Creed TA, Gutner CA, DeRubeis R, Barnett PG, Kuhn E, Suvak M, Owen J, Vogt D, Jo B, Schoenwald S, Johnson C, Mallard K, Beristianos M, La Bash H.

Implement Sci. 2018 May 22;13(1):69. doi: 10.1186/s13012-018-0756-3.

5.

Comparison of Accessibility, Cost, and Quality of Elective Coronary Revascularization Between Veterans Affairs and Community Care Hospitals.

Barnett PG, Hong JS, Carey E, Grunwald GK, Joynt Maddox K, Maddox TM.

JAMA Cardiol. 2018 Feb 1;3(2):133-141. doi: 10.1001/jamacardio.2017.4843.

6.

Mapping MOS-HIV to HUI3 and EQ-5D-3L in Patients With HIV.

Joyce VR, Sun H, Barnett PG, Bansback N, Griffin SC, Bayoumi AM, Anis AH, Sculpher M, Cameron W, Brown ST, Holodniy M, Owens DK.

MDM Policy Pract. 2017 Jul 3;2(2):2381468317716440. doi: 10.1177/2381468317716440. eCollection 2017 Jul-Dec.

7.

Changes in Veteran Tobacco Use Identified in Electronic Medical Records.

Barnett PG, Chow A, Flores NE, Sherman SE, Duffy SA.

Am J Prev Med. 2017 Jul;53(1):e9-e18. doi: 10.1016/j.amepre.2017.01.009. Epub 2017 Feb 10.

PMID:
28190690
8.

Emergent Challenges in Determining Costs for Economic Evaluations.

Jacobs JC, Barnett PG.

Pharmacoeconomics. 2017 Feb;35(2):129-139. doi: 10.1007/s40273-016-0465-1. Review.

PMID:
27838912
9.

Cost-Effectiveness of Treatments for Genotype 1 Hepatitis C Virus Infection in non-VA and VA Populations.

Liu S, Barnett PG, Holodniy M, Lo J, Joyce VR, Gidwani R, Asch SM, Owens DK, Goldhaber-Fiebert JD.

MDM Policy Pract. 2016 Jul-Dec;1. doi: 10.1177/2381468316671946. Epub 2016 Oct 3.

10.

Evaluating Two Measures of Lumbar Spine MRI Overuse: Administrative Data Versus Chart Review.

Avoundjian T, Gidwani R, Yao D, Lo J, Sinnott P, Thakur N, Barnett PG.

J Am Coll Radiol. 2016 Sep;13(9):1057-66. doi: 10.1016/j.jacr.2016.04.013. Epub 2016 Jun 22.

PMID:
27344246
11.

How Will New Guidelines Affect CD4 Testing in Veterans With HIV?

Barnett PG, Schmitt SK, Yu W, Goetz MB, Ohl ME, Asch SM.

Clin Infect Dis. 2016 Jul 1;63(1):96-100. doi: 10.1093/cid/ciw194. Epub 2016 Apr 3.

12.

Health-related quality of life among veterans in addictions treatment: identifying behavioral targets for future intervention.

Oppezzo MA, Michalek AK, Delucchi K, Baiocchi MT, Barnett PG, Prochaska JJ.

Qual Life Res. 2016 Aug;25(8):1949-57. doi: 10.1007/s11136-016-1236-3. Epub 2016 Feb 17.

13.

Inappropriate ordering of lumbar spine magnetic resonance imaging: are providers Choosing Wisely?

Gidwani R, Sinnott P, Avoundjian T, Lo J, Asch SM, Barnett PG.

Am J Manag Care. 2016 Feb 1;22(2):e68-76.

14.

Cost-effectiveness of smoking cessation treatment initiated during psychiatric hospitalization: analysis from a randomized, controlled trial.

Barnett PG, Wong W, Jeffers A, Hall SM, Prochaska JJ.

J Clin Psychiatry. 2015 Oct;76(10):e1285-91. doi: 10.4088/JCP.14m09016.

15.

Cost-Effectiveness of Integrating Tobacco Cessation Into Post-Traumatic Stress Disorder Treatment.

Barnett PG, Jeffers A, Smith MW, Chow BK, McFall M, Saxon AJ.

Nicotine Tob Res. 2016 Mar;18(3):267-74. doi: 10.1093/ntr/ntv094. Epub 2015 May 4.

16.

Uptake and utilization of directly acting antiviral medications for hepatitis C infection in U.S. veterans.

Gidwani R, Barnett PG, Goldhaber-Fiebert JD, Asch SM, Lo J, Dally SK, Owens DK.

J Viral Hepat. 2015 May;22(5):489-95. doi: 10.1111/jvh.12344. Epub 2014 Nov 24.

17.

Effect of management strategies and clinical status on costs of care for advanced HIV.

Barnett PG, Chow A, Joyce VR, Bayoumi AM, Griffin SC, Sun H, Holodniy M, Brown ST, Cameron W, Sculpher M, Youle M, Anis AH, Owens DK.

Am J Manag Care. 2014 May;20(5):e129-37.

PMID:
25326927
18.

Health care expenditures attributable to smoking in military veterans.

Barnett PG, Hamlett-Berry K, Sung HY, Max W.

Nicotine Tob Res. 2015 May;17(5):586-91. doi: 10.1093/ntr/ntu187. Epub 2014 Sep 19.

19.

ACC/AHA statement on cost/value methodology in clinical practice guidelines and performance measures: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures and Task Force on Practice Guidelines.

Anderson JL, Heidenreich PA, Barnett PG, Creager MA, Fonarow GC, Gibbons RJ, Halperin JL, Hlatky MA, Jacobs AK, Mark DB, Masoudi FA, Peterson ED, Shaw LJ.

J Am Coll Cardiol. 2014 Jun 3;63(21):2304-22. doi: 10.1016/j.jacc.2014.03.016. Epub 2014 Mar 27. No abstract available.

20.

ACC/AHA statement on cost/value methodology in clinical practice guidelines and performance measures: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures and Task Force on Practice Guidelines.

Anderson JL, Heidenreich PA, Barnett PG, Creager MA, Fonarow GC, Gibbons RJ, Halperin JL, Hlatky MA, Jacobs AK, Mark DB, Masoudi FA, Peterson ED, Shaw LJ; ACC/AHA Task Force on Performance Measures; ACC/AHA Task Force on Practice Guidelines.

Circulation. 2014 Jun 3;129(22):2329-45. doi: 10.1161/CIR.0000000000000042. Epub 2014 Mar 27. No abstract available.

PMID:
24677315
21.

Cost-effectiveness of extended cessation treatment for older smokers.

Barnett PG, Wong W, Jeffers A, Munoz R, Humfleet G, Hall S.

Addiction. 2014 Feb;109(2):314-22. doi: 10.1111/add.12404. Epub 2013 Dec 13.

22.

Cost-effectiveness of newer antiretroviral drugs in treatment-experienced patients with multidrug-resistant HIV disease.

Bayoumi AM, Barnett PG, Joyce VR, Griffin SC, Sun H, Bansback NJ, Holodniy M, Sanders G, Brown ST, Kyriakides TC, Angus B, Cameron DW, Anis AH, Sculpher M, Owens DK.

J Acquir Immune Defic Syndr. 2013 Dec 1;64(4):382-91. doi: 10.1097/QAI.0000000000000002.

23.

Assessment of Alternative Treatment Strategies for Chronic Genotype 1 Hepatitis C [Internet].

Goldhaber-Fiebert JD, Barnett PG, Dally S, Asch SM, Liu S, Cipriano L, Owens DK, Miake-Lye IM, Beroes JM, Shekelle PG.

Washington (DC): Department of Veterans Affairs; 2013 Mar.

24.

Cost and cost-effectiveness in a randomized trial of long-acting risperidone for schizophrenia.

Barnett PG, Scott JY, Krystal JH, Rosenheck RA; CSP 555 Research Group.

J Clin Psychiatry. 2012 May;73(5):696-702. doi: 10.4088/JCP.11m07070.

PMID:
22697193
25.

Reducing costs of acute care for ambulatory care-sensitive medical conditions: the central roles of comorbid mental illness.

Yoon J, Yano EM, Altman L, Cordasco KM, Stockdale SE, Chow A, Barnett PG, Rubenstein LV.

Med Care. 2012 Aug;50(8):705-13. doi: 10.1097/MLR.0b013e31824e3379.

PMID:
22437618
26.

Longer length of stay is not associated with better outcomes in VHA's substance abuse residential rehabilitation treatment programs.

Harris AH, Kivlahan D, Barnett PG, Finney JW.

J Behav Health Serv Res. 2012 Jan;39(1):68-79. doi: 10.1007/s11414-011-9250-2.

PMID:
21732222
27.

Determinants of the cost of health services used by veterans with HIV.

Barnett PG, Chow A, Joyce VR, Bayoumi AM, Griffin SC, Nosyk B, Holodniy M, Brown ST, Sculpher M, Anis AH, Owens DK.

Med Care. 2011 Sep;49(9):848-56. doi: 10.1097/MLR.0b013e31821b34c0.

PMID:
21610542
28.

How do clinical trial participants compare to other patients with schizophrenia?

Barnett PG, Scott JY, Rosenheck RA; CSP 555 Study Group.

Schizophr Res. 2011 Aug;130(1-3):34-9. doi: 10.1016/j.schres.2011.03.033. Epub 2011 Apr 22.

PMID:
21514794
29.

Effect of treatment interruption and intensification of antiretroviral therapy on health-related quality of life in patients with advanced HIV: a randomized, controlled trial.

Joyce VR, Barnett PG, Chow A, Bayoumi AM, Griffin SC, Sun H, Holodniy M, Brown ST, Kyriakides TC, Cameron DW, Youle M, Sculpher M, Anis AH, Owens DK.

Med Decis Making. 2012 Jan-Feb;32(1):70-82. doi: 10.1177/0272989X10397615. Epub 2011 Mar 7.

PMID:
21383086
30.

Long-acting risperidone and oral antipsychotics in unstable schizophrenia.

Rosenheck RA, Krystal JH, Lew R, Barnett PG, Fiore L, Valley D, Thwin SS, Vertrees JE, Liang MH; CSP555 Research Group.

N Engl J Med. 2011 Mar 3;364(9):842-51. doi: 10.1056/NEJMoa1005987. Erratum in: N Engl J Med. 2011 Mar 31;364(13):1281.

PMID:
21366475
31.

Challenges in the design and conduct of controlled clinical effectiveness trials in schizophrenia.

Rosenheck RA, Krystal JH, Lew R, Barnett PG, Thwin SS, Fiore L, Valley D, Huang GD, Neal C, Vertrees JE, Liang MH; CSP 555 Research Group.

Clin Trials. 2011 Apr;8(2):196-204. doi: 10.1177/1740774510392931. Epub 2011 Jan 26.

PMID:
21270143
32.

The cost of concordance with opiate substitution treatment guidelines.

Barnett PG, Trafton JA, Humphreys K.

J Subst Abuse Treat. 2010 Sep;39(2):141-9. doi: 10.1016/j.jsat.2010.05.012. Epub 2010 Jul 3.

PMID:
20598830
33.
34.

PET scan 18F-fluorodeoxyglucose uptake and prognosis in patients with resected clinical stage IA non-small cell lung cancer.

Nair VS, Barnett PG, Ananth L, Gould MK; Veterans Affairs Solitary Nodule Accuracy Project Cooperative Studies Group.

Chest. 2010 May;137(5):1150-6. doi: 10.1378/chest.09-2356. Epub 2009 Dec 28.

PMID:
20038738
35.

An improved set of standards for finding cost for cost-effectiveness analysis.

Barnett PG.

Med Care. 2009 Jul;47(7 Suppl 1):S82-8. doi: 10.1097/MLR.0b013e31819e1f3f. Review.

PMID:
19536018
36.

Inventory of data sources for estimating health care costs in the United States.

Lund JL, Yabroff KR, Ibuka Y, Russell LB, Barnett PG, Lipscomb J, Lawrence WF, Brown ML.

Med Care. 2009 Jul;47(7 Suppl 1):S127-42. doi: 10.1097/MLR.0b013e3181a55c3e.

37.

Health care costing: data, methods, current applications.

Lipscomb J, Yabroff KR, Brown ML, Lawrence W, Barnett PG.

Med Care. 2009 Jul;47(7 Suppl 1):S1-6. doi: 10.1097/MLR.0b013e3181a7e401. No abstract available.

PMID:
19536004
38.

Advancing the science of health care costing.

Lipscomb J, Barnett PG, Brown ML, Lawrence W, Yabroff KR.

Med Care. 2009 Jul;47(7 Suppl 1):S120-6. doi: 10.1097/MLR.0b013e3181a9d366. No abstract available.

PMID:
19536003
39.

Cost and outcomes of patients with solitary pulmonary nodules managed with PET scans.

Barnett PG, Ananth L, Gould MK; Veterans Affairs Positron Emission Tomography Imaging in the Management of Patients with Solitary Pulmonary Nodules (VA SNAP) Cooperative Study Group.

Chest. 2010 Jan;137(1):53-9. doi: 10.1378/chest.08-0529. Epub 2009 Jun 12.

PMID:
19525359
40.

Comparison of costs and utilization among buprenorphine and methadone patients.

Barnett PG.

Addiction. 2009 Jun;104(6):982-92. doi: 10.1111/j.1360-0443.2009.02539.x.

PMID:
19466922
41.

Quality of life of patients with advanced HIV/AIDS: measuring the impact of both AIDS-defining events and non-AIDS serious adverse events.

Anis AH, Nosyk B, Sun H, Guh DP, Bansback N, Li X, Barnett PG, Joyce V, Swanson KM, Kyriakides TC, Holodniy M, Cameron DW, Brown ST; OPTIMA Team1.

J Acquir Immune Defic Syndr. 2009 Aug 15;51(5):631-9. doi: 10.1097/QAI.0b013e3181a4f00d.

PMID:
19430303
42.

Health-related quality of life in a randomized trial of antiretroviral therapy for advanced HIV disease.

Joyce VR, Barnett PG, Bayoumi AM, Griffin SC, Kyriakides TC, Yu W, Sundaram V, Holodniy M, Brown ST, Cameron W, Youle M, Sculpher M, Anis AH, Owens DK.

J Acquir Immune Defic Syndr. 2009 Jan 1;50(1):27-36. doi: 10.1097/QAI.0b013e31818ce6f3.

PMID:
19295332
43.

Effect of incentives for medication adherence on health care use and costs in methadone patients with HIV.

Barnett PG, Sorensen JL, Wong W, Haug NA, Hall SM.

Drug Alcohol Depend. 2009 Feb 1;100(1-2):115-21. doi: 10.1016/j.drugalcdep.2008.09.017. Epub 2008 Dec 3.

44.

Cost-effectiveness of percutaneous coronary intervention in optimally treated stable coronary patients.

Weintraub WS, Boden WE, Zhang Z, Kolm P, Zhang Z, Spertus JA, Hartigan P, Veledar E, Jurkovitz C, Bowen J, Maron DJ, O'Rourke R, Dada M, Teo KK, Goeree R, Barnett PG; Department of Veterans Affairs Cooperative Studies Program No. 424 (COURAGE Trial) Investigators and Study Coordinators.

Circ Cardiovasc Qual Outcomes. 2008 Sep;1(1):12-20. doi: 10.1161/CIRCOUTCOMES.108.798462.

PMID:
20031783
45.

Effect of PCI on quality of life in patients with stable coronary disease.

Weintraub WS, Spertus JA, Kolm P, Maron DJ, Zhang Z, Jurkovitz C, Zhang W, Hartigan PM, Lewis C, Veledar E, Bowen J, Dunbar SB, Deaton C, Kaufman S, O'Rourke RA, Goeree R, Barnett PG, Teo KK, Boden WE; COURAGE Trial Research Group, Mancini GB.

N Engl J Med. 2008 Aug 14;359(7):677-87. doi: 10.1056/NEJMoa072771.

PMID:
18703470
46.

The role of economics in the QUERI program: QUERI Series.

Smith MW, Barnett PG.

Implement Sci. 2008 Apr 22;3:20. doi: 10.1186/1748-5908-3-20.

47.

The cost-effectiveness of a smoking cessation program for out-patients in treatment for depression.

Barnett PG, Wong W, Hall S.

Addiction. 2008 May;103(5):834-40. doi: 10.1111/j.1360-0443.2008.02167.x.

PMID:
18412763
48.

Impact of the recall period on measuring health utilities for acute events.

Bansback N, Sun H, Guh DP, Li X, Nosyk B, Griffin S, Barnett PG, Anis AH; OPTIMA TEAM.

Health Econ. 2008 Dec;17(12):1413-9. doi: 10.1002/hec.1351.

PMID:
18404664
49.

A clinical model to estimate the pretest probability of lung cancer in patients with solitary pulmonary nodules.

Gould MK, Ananth L, Barnett PG; Veterans Affairs SNAP Cooperative Study Group.

Chest. 2007 Feb;131(2):383-8.

50.

Linking opioid-dependent hospital patients to drug treatment: Health care use and costs 6 months after randomization.

Barnett PG, Masson CL, Sorensen JL, Wong W, Hall S.

Addiction. 2006 Dec;101(12):1797-804.

PMID:
17156179

Supplemental Content

Loading ...
Support Center